| RS1554086554 |
KCNN2
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Global developmental delay |
| RS1554086647 |
TRIO
|
Health Risk |
Likely pathogenic |
— |
| RS1554086653 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1554086694 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1554086794 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1554086823 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial multiple polyposis syndrome, Familial adenomatous polyposis 1 |
| RS1554086850 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1554086854 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1554086862 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 1, Hereditary cancer-predisposing syndrome |
| RS1554086923 |
APC
|
Health Risk |
Likely pathogenic |
Familial multiple polyposis syndrome, Familial multiple polyposis syndrome |
| RS1554086935 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1554086974 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1554087023 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1554087036 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1554087070 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1554087123 |
APC
|
Health Risk |
Pathogenic |
Carcinoma of colon, Familial adenomatous polyposis 1 |
| RS1554087174 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1554087239 |
APC
|
Health Risk |
Pathogenic |
Carcinoma of colon, Carcinoma of colon |
| RS1554087314 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1554087379 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1554087390 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1554087395 |
ARSB
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1554087406 |
ARSB
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1554087423 |
ARSB
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1554087439 |
ARSB
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1554087441 |
ARSB
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1554087445 |
ARSB
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1554087461 |
SLC22A5
|
Health Risk |
Pathogenic |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS1554087474 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Hereditary cancer-predisposing syndrome |
| RS1554087491 |
SLC22A5
|
Health Risk |
Pathogenic |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS1554087515 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial multiple polyposis syndrome, Familial adenomatous polyposis 1 |
| RS1554087566 |
POU4F3
|
Health Risk |
Likely pathogenic |
— |
| RS1554087620 |
GABRA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic generalized epilepsy, Epilepsy |
| RS1554087719 |
SLC22A5
|
Health Risk |
Pathogenic |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS1554087829 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 1, Classic or attenuated familial adenomatous polyposis |
| RS1554087913 |
SLC22A5
|
Health Risk |
Likely pathogenic |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS1554087949 |
SLC22A5
|
Health Risk |
Likely pathogenic |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS1554087972 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1554087999 |
ARSB
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1554088002 |
ARSB
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1554088064 |
HINT1
|
Health Risk |
Likely pathogenic |
Autosomal recessive axonal neuropathy with neuromyotonia, Autosomal recessive axonal neuropathy with neuromyotonia |
| RS1554088079 |
ARSB
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1554088081 |
ARSB
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1554088099 |
ARSB
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1554088165 |
SLC22A5
|
Health Risk |
Pathogenic |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS1554088200 |
SLC22A5
|
Health Risk |
Likely pathogenic |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS1554088206 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1554088287 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, APC-related disorder |
| RS1554088313 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 1, Hereditary cancer-predisposing syndrome |
| RS1554088359 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1554088383 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 1, Hereditary cancer-predisposing syndrome |
| RS1554088391 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1554088413 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1554088578 |
SLC22A5
|
Health Risk |
Pathogenic |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS1554088582 |
APC
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1554088600 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1554088632 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1554088726 |
APC
|
Health Risk |
Likely pathogenic |
— |
| RS1554088762 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1554088768 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1554088780 |
APC
|
Health Risk |
Pathogenic |
— |
| RS1554088793 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1554089226 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1554089593 |
SPINK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pancreatitis, Hereditary pancreatitis |
| RS1554089838 |
ARSB
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1554089895 |
SPINK1
|
Health Risk |
Pathogenic |
Hereditary pancreatitis, Hereditary pancreatitis |
| RS1554090012 |
PDE6A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1554090072 |
ADGRV1
|
Health Risk |
Pathogenic |
Usher syndrome, Usher syndrome |
| RS1554090622 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1554090927 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1554091355 |
SQSTM1
|
Health Risk |
Pathogenic |
Neurodegeneration with ataxia, dystonia |
| RS1554091578 |
TRIO
|
Health Risk |
Likely pathogenic |
— |
| RS1554092890 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, DNAH5-related disorder |
| RS1554093168 |
SLC25A46
|
Health Risk |
Likely pathogenic |
Neuropathy, hereditary motor and sensory |
| RS1554093433 |
NKX2-5
|
Health Risk |
Pathogenic/Likely pathogenic |
Noncompaction cardiomyopathy, Primary dilated cardiomyopathy |
| RS1554093461 |
NKX2-5
|
Health Risk |
Pathogenic |
Atrial septal defect 7, Inborn genetic diseases |
| RS1554093487 |
NKX2-5
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Atrial septal defect 7 |
| RS1554093882 |
GABRB2
|
Health Risk |
Likely pathogenic |
— |
| RS1554093884 |
GABRB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, Developmental and epileptic encephalopathy 92 |
| RS1554093885 |
GABRB2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 92, Developmental and epileptic encephalopathy 92 |
| RS1554093889 |
GABRB2
|
Health Risk |
Pathogenic |
— |
| RS1554093891 |
GABRB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, Developmental and epileptic encephalopathy 92 |
| RS1554093894 |
GABRB2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 92, Developmental and epileptic encephalopathy 92 |
| RS1554094145 |
GABRB2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 92, Intellectual disability |
| RS1554094149 |
GABRB2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 92, Developmental and epileptic encephalopathy 92 |
| RS1554094278 |
GABRB2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1554094927 |
SGCD
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2F, Dilated cardiomyopathy 1L |
| RS1554094947 |
SGCD
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2F, Autosomal recessive limb-girdle muscular dystrophy type 2F |
| RS1554095084 |
SLC26A2
|
Health Risk |
Likely pathogenic |
Multiple epiphyseal dysplasia type 4, Multiple epiphyseal dysplasia type 4 |
| RS1554095097 |
SLC26A2
|
Health Risk |
Likely pathogenic |
Multiple epiphyseal dysplasia type 4, Multiple epiphyseal dysplasia type 4 |
| RS1554095125 |
SLC26A2
|
Health Risk |
Likely pathogenic |
Multiple epiphyseal dysplasia type 4, Multiple epiphyseal dysplasia type 4 |
| RS1554095137 |
SLC26A2
|
Health Risk |
Likely pathogenic |
Multiple epiphyseal dysplasia type 4, Multiple epiphyseal dysplasia type 4 |
| RS1554095145 |
SLC26A2
|
Health Risk |
Likely pathogenic |
Multiple epiphyseal dysplasia type 4, Multiple epiphyseal dysplasia type 4 |
| RS1554095154 |
SLC26A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple epiphyseal dysplasia type 4, Diastrophic dysplasia |
| RS1554095156 |
SLC26A2
|
Health Risk |
Likely pathogenic |
Multiple epiphyseal dysplasia type 4, Multiple epiphyseal dysplasia type 4 |
| RS1554095167 |
SLC26A2
|
Health Risk |
Likely pathogenic |
Multiple epiphyseal dysplasia type 4, Achondrogenesis |
| RS1554095263 |
SLC34A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi renotubular syndrome 2, Hypercalcemia |
| RS1554095266 |
SLC26A2
|
Health Risk |
Likely pathogenic |
Multiple epiphyseal dysplasia type 4, Multiple epiphyseal dysplasia type 4 |
| RS1554095296 |
SLC26A2
|
Health Risk |
Pathogenic |
Multiple epiphyseal dysplasia type 4, Achondrogenesis |
| RS1554095356 |
SLC26A2
|
Health Risk |
Likely pathogenic |
Multiple epiphyseal dysplasia type 4, Multiple epiphyseal dysplasia type 4 |